Core Viewpoint - The essence of the company's "anti-involution" strategy lies in continuously building irreplaceable core competencies, focusing on four key capabilities to strengthen its development foundation and competitive barriers [1] Group 1: Core Competencies - The company is systematically planning and focusing on four core capabilities: brand building in the health sector, forward-looking research and pipeline layout, comprehensive professional compliance promotion across channels, and a stable and efficient supply chain [1] Group 2: Revenue Growth Strategies - The company is pursuing both intrinsic growth and extrinsic expansion as dual drivers for revenue growth [1] - For intrinsic growth, the company aims to consolidate the leadership of its flagship products such as Changyanning, Qianlikang, and Zhixinfu, while exploring growth opportunities for potential products like Jindi, Niuhuang Shangqing capsules, and Jinaikang [1] - The company is also focused on identifying market opportunities and enhancing its research and development layout to strengthen its advantages in traditional Chinese medicine and actively pursue innovative drug development [1] Group 3: External Expansion - In terms of extrinsic expansion, the company plans to engage in equity mergers and acquisitions related to traditional Chinese medicine and rapidly acquire potential products through systematic business development [1]

Core Viewpoint - The company Kang En Bei has a diverse range of products related to influenza and cold treatment, including antiviral, cough relief, pain relief, anti-infection, and health enhancement products, with ongoing development of additional related products [2] Product Categories - Antiviral products include compound Houttuynia cordata granules, blue honeysuckle granules, and Niuhuang Shangqing capsules [2] - Cough relief products consist of acetylcysteine effervescent tablets, compound fresh bamboo liquid, and various syrups and oral liquids for children [2] - Pain relief and cold products feature ibuprofen granules, compound paracetamol and amantadine capsules, and other related formulations [2] - Anti-infection products include amoxicillin capsules and enteric-coated erythromycin tablets [2] - Health enhancement products comprise vitamins and protein powders [2] Recent Developments - The company has recently received approval for a new traditional Chinese medicine, Qinghouyan lozenges, which can alleviate throat discomfort caused by colds [2] - Other influenza and cold-related products are under development, with the Ivy leaf extract and oral liquid project currently in Phase II clinical trials, aimed at treating cough and phlegm associated with acute tracheobronchitis [2]

Core Viewpoint - 康恩贝 (600572.SH) is actively involved in the development and marketing of various medications related to influenza and colds, including antiviral, cough relief, pain relief, anti-infection, and immune-boosting products [1] Product Categories - The company offers antiviral products such as compound Houttuynia cordata granules, blue honeysuckle granules, and Niuhuang Shangqing capsules [1] - Cough relief products include acetylcysteine effervescent tablets, compound fresh bamboo liquid, and various syrups and oral liquids for children [1] - Pain relief and cold medications consist of ibuprofen granules, compound paracetamol and phenylephrine capsules, and other related products [1] - Anti-infection products include amoxicillin capsules and enteric-coated erythromycin tablets [1] - Immune-boosting products feature vitamins and protein powders, along with a newly approved traditional Chinese medicine, Qinghouyan lozenges, for symptomatic relief of throat discomfort caused by colds [1] Research and Development - The company is advancing its research plans for other influenza and cold-related products, with the Ivy leaf extract and oral liquid project currently in Phase II clinical trials, aimed at treating cough and phlegm associated with acute tracheobronchitis [1]

Core Viewpoint - The company 康恩贝 (600572.SH) has a diverse range of products related to influenza and cold treatment, including antiviral, cough relief, pain relief, anti-infection, and immunity-enhancing products [1] Product Categories - Antiviral products include compound Houttuynia cordata granules, Lianqiao granules, and Niuhuang Shangqing capsules [1] - Cough relief products consist of acetylcysteine effervescent tablets, compound fresh bamboo liquid, and various syrups and oral liquids for children [1] - Pain relief and cold products feature ibuprofen granules, compound paracetamol and amantadine capsules, and other related formulations [1] - Anti-infection products include amoxicillin capsules and erythromycin enteric-coated tablets [1] - Immunity-enhancing products comprise vitamins and protein powders, along with a newly approved traditional Chinese medicine for throat discomfort relief [1] Research and Development - The company is advancing its research plans for other influenza and cold-related products, with a project involving ivy leaf extract and oral liquid currently in Phase II clinical trials, aimed at treating cough and phlegm associated with acute tracheobronchitis [1]